A study has found that the psychedelic drug MDMA, combined with talk therapy, can reduce symptoms of post-traumatic stress disorder.

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.

  • treefrog@lemm.ee
    21·
    1 year ago

    DXM is way more abusuable than psychedelics. And, as I said, Wellbutrin is a serious liver enzyme inhibitor that won’t allow you to take any drug processed through that pathway without serious side effects.

    The drug combination works by shutting down one of DXMs metabolic pathways. But because it has two, instead of causing you to overdose, it just doesn’t metabolize into DXO (a much stronger disassociative).

    And both chemicals cause physical withdrawal. And, DXM itself can be addictive in a psychological sense.

    I understand the hype, DXM is a fascinating compound and this is an interesting way to use it. But the drug does have serious side effects and tons of drug interactions because of the liver enzyme inhibition.

    I don’t think it’s the magic bullet the pharmaicutical industry pretends it is. And having tried it myself, it wasn’t a game changer but rather made me feel like shit and made me paranoid to put any other compound in my body.